lithocholic acid has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajaj, A; Dasgupta, U; Kar, A; Komalla, V; Kumar, S; Mukhopadhyay, A; Pal, S; Sengupta, S; Sharma, H; Sharma, RD; Sharma, Y; Shyam, R; Sreekanth, V; Yadav, P | 1 |
| Befeler, A; Keach, J; Kowdley, KV; Lindor, K; Marschall, HU; Sinakos, E | 1 |
2 other study(ies) available for lithocholic acid and Disease Exacerbation
| Article | Year |
|---|---|
Bile Acid Tethered Docetaxel-Based Nanomicelles Mitigate Tumor Progression through Epigenetic Changes.
Topics: Animals; Antineoplastic Agents; Calcium-Binding Proteins; Cell Line, Tumor; CpG Islands; Demethylation; Disease Progression; Docetaxel; Epigenesis, Genetic; Extracellular Matrix Proteins; Female; Lithocholic Acid; Mice, Inbred BALB C; Micelles; Neoplasms; Surface-Active Agents | 2021 |
Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.
Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lithocholic Acid; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2010 |